4Schochet SS, Mcgormick WF. Neuropathology case studies. New York:Medical Examination Publishing, 1979. 403.
5Minassian BA, Ianzano L, Meloche M, et al. Muration spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy. Neurology, 2000,55(3) :341.
4Taylor JP,Hardy J,Fischbeck KH.Toxic proteins in neurodegenerative disease[J].Science,2002,296(5575):1991-1995.
5Hansrote S,Croul S,Selak M,et al.External ophthalmoplegia with severe progressive multiorgan involvement associated with the mtDNA A3243G mutation[J].J Neurol Sci,2002,197:63-67.
6Sciacco M,Prelle A,Comi GP,et al.Retrospective study of a large population of patients affected with mitochondrial disorders:clinical,morphological and molecular genetic evaluation[J].J Neurol,2001,248(9):778-788.
8Wiedemann FR1,Bartels C,Kirches E,et al.Unusual presentations of patients with the mitochondrial MERRF mutation A8344G[J].Clinical Neurology and Neurosurgery,2008,110(8):859-863.
9Kim YJ,Noguchi S,Hayashi YK,et al.The product of an oculopharyngealmuscular dystrophy gene,poly(A)2-binding protein2,interacts with SKIP and stimulates muscle-specific gene expression[J].Hum Mol Genet,2001,10(11):1129-1139.
10Fukuhara N,Tokiguchi S,Shirakaua K,et al.Myoclonus epilepsy associated with ragged-red fibres(mitochondrial abnormalities):disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature[J].J Neurol Sci,1980,47(1):117-133.
